Longbow Capital
Longbow Capital is a private equity investment management firm based in Calgary, Alberta, established in 1997. The company specializes in growth and expansion investments, primarily targeting the energy and technology sectors. Longbow Capital focuses on companies that contribute to energy efficiency and sustainability, seeking to enhance the value chain across the energy, power, and industrial sectors in both the United States and Canada. Through its Energy Transition Fund, launched in 2022, the firm aims to invest in businesses that provide innovative energy solutions and B2B services, promoting environmentally responsible practices while achieving cost-effective energy delivery.
Clir Renewables Inc. specializes in developing cloud-based software for renewable energy asset management and reporting. Founded in 2016 and headquartered in Vancouver, Canada, with an office in Glasgow, United Kingdom, Clir's software-as-a-service platform aims to enhance the performance and profitability of renewable energy plants. By integrating advanced artificial intelligence with deep domain expertise, the platform assists asset managers and owners in optimizing annual energy production, monitoring asset health, and managing both financial and technical risks.
VoltaGrid LLC, based in Bellaire, Texas, is an energy company that specializes in advanced energy management and generation solutions. Established in 2020, VoltaGrid focuses on enhancing power quality and reliability through its innovative platform. The company provides a portable and scalable power system that integrates natural gas and grid power, catering to clients in various industries including pressure pumping, remote mining, utility, and distributed generation. VoltaGrid's technology aims to significantly reduce emissions and fuel consumption, promoting efficiency in energy use.
Domainex Ltd is a contract research company that was established in 2001 and operates from Cambridge UK. In May 2007 Domainex merged with NCE Discovery to form a new integrated company with capabilities in biology and chemistry.
Service division offers technologies designed to clone and express challenging genes to give high-quality recombinant protein displaying functional domains of the target. We also provide computational and medicinal chemistry for the design and synthesis of candidate drugs aimed at our customers' target proteins.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.